We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
(-11%)
Cap. Flow
-$51.9M
Cap. Flow
% of AUM
-12.95%
Top 10 Holdings %
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2
Avg Time Held
2.6
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immix Biopharma
IMMX
|
+$3.29M |
| 2 |
Cue Biopharma
CUE
|
+$2.35M |
| 3 |
Modular Medical
MODD
|
+$1.25M |
| 4 |
Ideal Power
IPWR
|
+$1.2M |
| 5 |
Talkspace
TALK
|
+$680K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brunswick
BC
|
+$48.4M |
| 2 |
Linde
LIN
|
+$11M |
| 3 |
bluebird bio
BLUE
|
+$1.87M |
| 4 |
SLGCW
SomaLogic, Inc. Warrant
SLGCW
|
+$1.68K |
| 5 |
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
|
+$323 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.85% |
| 2 | Healthcare | 21.24% |
| 3 | Industrials | 16.95% |
| 4 | Materials | 10.55% |
| 5 | Consumer Discretionary | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
DELISTED
Cue Health Inc. Common Stock
HLTH
| $189K | 0.05% |
1,000,000
| – | – |
2021 Q3
10 quarters
|
|
52
DELISTED
ARKO Corp Warrant
ARKOW
| $165K | 0.04% |
333,333
| – | – |
2020 Q4
13 quarters
|
|
53
Advanced Micro Devices
AMD
$918B
| $165K | 0.04% |
913
| – | – |
2022 Q1
8 quarters
|
|
54
Cadence Design Systems
CDNS
$89.3B
| $163K | 0.04% |
525
| – | – |
2020 Q2
15 quarters
|
|
|
LGF.B
55
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $153K | 0.04% |
16,413
| – | – |
2019 Q4
17 quarters
|
|
56
ExxonMobil
XOM
$718B
| $125K | 0.03% |
1,075
| – | – |
2020 Q2
15 quarters
|
|
57
Liberty Latin America Class C
LILAK
$1.6B
| $115K | 0.03% |
18,174
| – | – |
2020 Q2
15 quarters
|
|
58
Bank of New York Mellon
BNY
$96.4B
| $115K | 0.03% |
2,000
| – | – |
2020 Q1
16 quarters
|
|
59
AbbVie
ABBV
$501B
| $93.8K | 0.02% |
515
| – | – |
2020 Q2
15 quarters
|
|
60
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $72.2K | 0.02% |
16,667
| – | – |
2023 Q4
1 quarter
|
|
61
DELISTED
CompoSecure Inc Warrant
CMPOW
| $70K | 0.02% |
100,000
| – | – |
2022 Q1
8 quarters
|
|
62
Teradyne
TER
$53.7B
| $67.7K | 0.02% |
600
| – | – |
2020 Q2
15 quarters
|
|
63
Altria Group
MO
$123B
| $52.3K | 0.01% |
1,200
| – | – |
2020 Q2
15 quarters
|
|
64
Revolution Medicines Inc Warrant
RVMDW
$108M
| $36.5K | 0.01% |
200,000
| – | – |
2023 Q4
1 quarter
|
|
65
ARK Blockchain & Fintech Innovation ETF
ARKF
$912M
| $36.4K | 0.01% |
1,200
| – | – |
2022 Q1
8 quarters
|
|
66
Lumentum
LITE
$78.8B
| $31.3K | 0.01% |
660
| – | – |
2020 Q2
15 quarters
|
|
67
AT&T
T
$161B
| $29K | 0.01% |
1,650
| – | – |
2020 Q2
15 quarters
|
|
68
Liberty Latin America Class A
LILA
$1.62B
| $28K | 0.01% |
5,913
| – | – |
2020 Q1
16 quarters
|
|
69
ARK Next Generation Technology ETF
ARKW
$2.25B
| $25K | 0.01% |
300
| – | – |
2022 Q1
8 quarters
|
|
70
X4 Pharmaceuticals
XFOR
$262M
| $24.8K | 0.01% |
596
| – | – |
2019 Q4
17 quarters
|
|
71
ARK Genomic Revolution ETF
ARKG
$2.09B
| $23.7K | 0.01% |
825
| – | – |
2022 Q1
8 quarters
|
|
72
DELISTED
OppFi Inc Warrants
OPFI.WS
| $20K | 0.01% |
250,000
| – | – |
2021 Q3
10 quarters
|
|
|
73
Revolution Medicines
RVMD
$40.6B
| $17.9K | ﹤0.01% |
556
| – | – |
2023 Q4
1 quarter
|
|
74
SaverOne 2014 Ltd Warrant
SVREW
$63.2K
| $10.2K | ﹤0.01% |
121,000
| – | – |
2022 Q2
7 quarters
|
|
75
Alliance Entertainment Holding Corp Warrants
AENTW
| $7K | ﹤0.01% |
200,000
| – | – |
2023 Q2
3 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q1 2024 Portfolio in Review
As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.
- Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
- Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
- Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
- Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
- Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
- Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
- Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.
Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.